Molecular Detection and Phylogenetic Analysis of Anaplasma Species in Ticks from Three Provinces of China
Vector-Borne and Zoonotic Diseases · 2025
DOI: 10.1089/vbz.2024.0134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vector-Borne and Zoonotic Diseases, 2025. Verfasst von Yuqing Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chinese Center for Disease Control and Prevention, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National …. Hauptthemen laut MEDLINE: Anaplasma, Ticks, Ixodidae. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Anaplasmosis, caused by Anaplasma species, poses significant threats to public health and livestock productivity. Understanding the distribution and genetic diversity of these pathogens in tick vectors across China is critical for risk assessment and disease control. Materials and Methods: From April to June 2023, 875 ticks were collected across three Chinese provinces: Jiangxi, Yunnan, and Shaanxi. The collected ticks comprised Rhipicephalus microplus (from Jiangxi and Yunnan) and Haemaphysalis longicornis (from Shaanxi). Pathogen detection was performed using PCR, followed by phylogenetic analysis of the obtained sequences to determine genetic relationships.
Results
Anaplasma capra was detected predominantly in R. microplus from Yudu County, Jiangxi (4.95%), and in H. longicornis from Meixian County (3.16%), Long County (5.99%), and Zhenba County (0.83%) in Shaanxi, exhibiting regional genetic variations. The detection rate of Anaplasma marginale was 6.59% in Yudu County, Jiangxi; significantly higher rates were found in Yunnan province: 41.75% in Nanjian County, 40.38% in Weishan County, and 52.04% in Yongsheng County. Phylogenetic analysis revealed that A. marginale isolates from Lijiang (Yongsheng), Yunnan, were highly homologous (99.63%-100%) to those from Yudu County, Jiangxi, while isolates from Dali (Nanjian and Weishan), Yunnan, formed a distinct clade.
Conclusion
The findings demonstrate the widespread distribution of A. capra and A. marginale in ticks across the surveyed regions of China, with notable variations in prevalence and genetic characteristics. These pathogens represent potential threats to local residents and livestock. Future research should expand the geographic sampling range to fully understand their distribution patterns and explore effective prevention and control strategies to safeguard public health and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chinese Center for Disease Control and Prevention, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Beijing, Ch…
- Yunnan Institute of Endemic Diseases Control and Prevention, Yunnan Provincial Key Laboratory of Natural Focal Disease Control and Prevention, Yunnan, People's Republic of China.
- Jiangxi Provincial Center for Disease Control and Prevention, Nanchang City, China.
- Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Zitieren
APA
Cheng, Y., Yuan, Q., Yang, M., Liang, J., Teng, Z., Huang, Q., Lu, M., & Qin, T. (2025). Molecular Detection and Phylogenetic Analysis of Anaplasma Species in Ticks from Three Provinces of China. Vector-Borne and Zoonotic Diseases. https://doi.org/10.1089/vbz.2024.0134
Vancouver
Cheng Y, Yuan Q, Yang M, Liang J, Teng Z, Huang Q, et al. Molecular Detection and Phylogenetic Analysis of Anaplasma Species in Ticks from Three Provinces of China. Vector-Borne and Zoonotic Diseases. 2025. doi:10.1089/vbz.2024.0134
BibTeX
@article{Cheng2025,
author = {Cheng, Yuqing and Yuan, Qinghong and Yang, Meng and Liang, Junrong and Teng, Zhongqiu and Huang, Qingzhu and Lu, Miao and Qin, Tian},
title = {Molecular Detection and Phylogenetic Analysis of Anaplasma Species in Ticks from Three Provinces of China},
journal = {Vector-Borne and Zoonotic Diseases},
year = {2025},
doi = {10.1089/vbz.2024.0134}
}
EUVIMED